AJP - Renal AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 270: F806-F811, 1996;
0363-6127/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoo, T.
Right arrow Articles by Kitamura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoo, T.
Right arrow Articles by Kitamura, M.

AJP - Renal Physiology, Vol 270, Issue 5 806-F811, Copyright © 1996 by American Physiological Society


ARTICLES

Antioxidant PDTC induces stromelysin expression in mesangial cells via a tyrosine kinase-AP-1 pathway

T. Yokoo and M. Kitamura
Department of Medicine, University College London Medical School, United Kingdom.

We found that pyrrolidine dithiocarbamate (PDTC) induces the matrix metalloproteinase stromelysin in cultured glomerular mesangial cells. Although PDTC is a well-known inhibitor of nuclear factor-kappa B (NF-kappa B), this effect was independent of the NF-kappa B activity, since overexpression of a dominant negative mutant of p50 NF-kappa B subunit repressed activity of the kappa B site, whereas it failed to induce stromelysin. To elucidate the intracellular mechanisms involved, we focused on the role of activator protein 1 (AP-1), since its binding site, the 12-O-tetradecanoylphorbol 13-acetate (TPA) response element (TRE), is located in the 5'-flanking region of the stromelysin gene. Northern blot analysis revealed that PDTC upregulated expression of c-jun and c-fos before the expression of stromelysin. Transient transfection studies using a TRE-LacZ reporter plasmid elucidated that activity of AP-1 was significantly increased by PDTC. Stable transfection with a c-jun antisense cDNA or pretreatment with curcumin, a pharmacological inhibitor of c-Jun/AP-1, revealed that inactivation of AP-1 diminished the induction of stromelysin by PDTC. To identify the machinery involved upstream of AP-1 activation, the role of tyrosine kinases was investigated. Western blot analysis showed that PDTC induced phosphorylation of tyrosine kinases. Treatment of mesangial cells with tyrosine kinase inhibitors suppressed activation of AP-1 as well as induction of stromelysin by PDTC. These findings demonstrate that the antioxidant PDTC induces stromelysin expression via stimulation of the tyrosine kinase-AP-1 pathway independent of its suppressive action on NF-kappa B.


This article has been cited by other articles:


Home page
ThoraxHome page
Z Liu and J Klominek
Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors
Thorax, March 1, 2003; 58(3): 198 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Nakayama, A. Furusu, Q. Xu, T. Konta, and M. Kitamura
Unexpected Transcriptional Induction of Monocyte Chemoattractant Protein 1 by Proteasome Inhibition: Involvement of the c-Jun N-Terminal Kinase-Activator Protein 1 Pathway
J. Immunol., August 1, 2001; 167(3): 1145 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. NAITO, M. S. RAZZAQUE, A. NAZNEEN, D. LIU, H. NIHEI, T. KOJI, and T. TAGUCHI
Renal Expression of the Ets-1 Proto-oncogene during Progression of Rat Crescentic Glomerulonephritis
J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2243 - 2255.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
Y. ISHIKAWA, H. SUGIYAMA, E. STYLIANOU, and M. KITAMURA
Bioflavonoid Quercetin Inhibits Interleukin-1-Induced Transcriptional Expression of Monocyte Chemoattractant Protein-1 in Glomerular Cells via Suppression of Nuclear Factor-{kappa}B
J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2290 - 2296.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Thaloor, K. J. Miller, J. Gephart, P. O. Mitchell, and G. K. Pavlath
Systemic administration of the NF-kappa B inhibitor curcumin stimulates muscle regeneration after traumatic injury
Am J Physiol Cell Physiol, August 1, 1999; 277(2): C320 - C329.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Moreno-Manzano, Y. Ishikawa, J. Lucio-Cazana, and M. Kitamura
Suppression of Apoptosis by All-trans-Retinoic Acid. DUAL INTERVENTION IN THE c-JUN N-TERMINAL KINASE-AP-1 PATHWAY
J. Biol. Chem., July 16, 1999; 274(29): 20251 - 20258.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. Morin, W. Q. Li, S. Su, M. Ahmad, and M. Zafarullah
Induction of Stromelysin Gene Expression by Tumor Necrosis Factor alpha  Is Inhibited by Dexamethasone, Salicylate, and N-Acetylcysteine in Synovial Fibroblasts
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1634 - 1640.
[Abstract] [Full Text]


Home page
BloodHome page
M. H. Khandaker, G. Mitchell, L. Xu, J. D. Andrews, R. Singh, H. Leung, J. Madrenas, S. S.G. Ferguson, R. D. Feldman, and D. J. Kelvin
Metalloproteinases Are Involved in Lipopolysaccharide- and Tumor Necrosis Factor-alpha -Mediated Regulation of CXCR1 and CXCR2 Chemokine Receptor Expression
Blood, April 1, 1999; 93(7): 2173 - 2185.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online